BioSpace

Third FDA Rejection for Aldeyra’s Dry Eye Disease Drug Sends Shares Plummeting

In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...
InvestorsHub on MSN

Aldeyra receives FDA rejection for dry eye treatment reproxalap

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) said it has received a Complete Response Letter from the U.S. Food and Drug Administration rejecting its New Drug Application for reproxalap, a proposed ...

FDA rejects Aldeyra's dry eye drug for third time, stock crashes 68%

Aldeyra Therapeutics Inc. ALDX shares are tumbling on Tuesday following the U.S. Food and Drug Administration (FDA) update.

8 Best Sleep Masks for Better Rest, According to Testing, Experts, and Reviews

Many products can help, but among the most effective is a sleep mask. The best sleep masks “help block light, which is one of ...

The Best Tower 28 Products for Even the Most Sensitive Skin

Built around hypochlorous acid and designed for reactive skin, these dermatologist-tested products have quietly become the ...